These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12386001)

  • 1. Selecting targets for therapeutic validation through differential protein expression using chromatography-mass spectrometry.
    Patterson S
    Bioinformatics; 2002; 18 Suppl 2():S181. PubMed ID: 12386001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma.
    Kuo KK; Kuo CJ; Chiu CY; Liang SS; Huang CH; Chi SW; Tsai KB; Chen CY; Hsi E; Cheng KH; Chiou SH
    Pancreas; 2016 Jan; 45(1):71-83. PubMed ID: 26262590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of differentially expressed proteins from primary versus metastatic pancreatic cancer cells using subcellular proteomics.
    McKinney KQ; Lee JG; Sindram D; Russo MW; Han DK; Bonkovsky HL; Hwang SI
    Cancer Genomics Proteomics; 2012; 9(5):257-63. PubMed ID: 22990105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proteome analysis--basis for individualized pancreatic carcinoma therapy?].
    Löhr JM; Faissner R; Findeisen P; Neumaier M
    Internist (Berl); 2006 Jun; 47 Suppl 1():S40-8. PubMed ID: 16773365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-model statistical approach for proteomic spectral count quantitation.
    Branson OE; Freitas MA
    J Proteomics; 2016 Jul; 144():23-32. PubMed ID: 27260494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications.
    Jimenez CR; Verheul HM
    Am Soc Clin Oncol Educ Book; 2014; ():e504-10. PubMed ID: 24857147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural templates predict novel protein interactions and targets from pancreas tumour gene expression data.
    Dawelbait G; Winter C; Zhang Y; Pilarsky C; Grützmann R; Heinrich JC; Schroeder M
    Bioinformatics; 2007 Jul; 23(13):i115-24. PubMed ID: 17646287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of pancreatic cancer-specific cell-surface markers for development of targeting ligands.
    Morse DL; Hostetter G; Balagurunathan Y; Gillies RJ; Han H
    Methods Mol Biol; 2010; 624():195-210. PubMed ID: 20217597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the protein expression profiles of breast cancer cell lines by quantitative proteomics using iTRAQ labelling and tandem mass spectrometry.
    Calderón-González KG; Valero Rustarazo ML; Labra-Barrios ML; Bazán-Méndez CI; Tavera-Tapia A; Herrera-Aguirre ME; Sánchez del Pino MM; Gallegos-Pérez JL; González-Márquez H; Hernández-Hernández JM; León-Ávila G; Rodríguez-Cuevas S; Guisa-Hohenstein F; Luna-Arias JP
    J Proteomics; 2015 Jun; 124():50-78. PubMed ID: 25918110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery.
    Yu KH; Barry CG; Austin D; Busch CM; Sangar V; Rustgi AK; Blair IA
    J Proteome Res; 2009 Mar; 8(3):1565-76. PubMed ID: 19199705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target discovery and validation in pancreatic cancer.
    Beaty RM; Gronborg M; Pollack JR; Maitra A
    Methods Mol Biol; 2007; 360():57-89. PubMed ID: 17172725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy.
    Ralhan R; Desouza LV; Matta A; Tripathi SC; Ghanny S; Dattagupta S; Thakar A; Chauhan SS; Siu KW
    J Proteome Res; 2009 Jan; 8(1):300-9. PubMed ID: 19072117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide differential display of serum-free conditioned medium from cancer cell lines.
    Sato K; Sasaki K; Tsao MS; Yamaguchi K
    Cancer Lett; 2002 Feb; 176(2):199-203. PubMed ID: 11804748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach.
    Park J; Lee E; Park KJ; Park HD; Kim JW; Woo HI; Lee KH; Lee KT; Lee JK; Park JO; Park YS; Heo JS; Choi SH; Choi DW; Jang KT; Lee SY
    Oncotarget; 2017 Jun; 8(26):42761-42771. PubMed ID: 28514751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry-based expression profiling of clinical prostate cancer.
    Wright ME; Han DK; Aebersold R
    Mol Cell Proteomics; 2005 Apr; 4(4):545-54. PubMed ID: 15695425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.
    Shen J; Person MD; Zhu J; Abbruzzese JL; Li D
    Cancer Res; 2004 Dec; 64(24):9018-26. PubMed ID: 15604267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiling of more than 3500 proteins of MSS-type colorectal cancer by stable isotope labeling and mass spectrometry.
    Kang UB; Yeom J; Kim HJ; Kim H; Lee C
    J Proteomics; 2012 Jun; 75(10):3050-62. PubMed ID: 22154799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
    Iacobuzio-Donahue CA; Ashfaq R; Maitra A; Adsay NV; Shen-Ong GL; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
    Cancer Res; 2003 Dec; 63(24):8614-22. PubMed ID: 14695172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphoproteomics by mass spectrometry and classical protein chemistry approaches.
    Salih E
    Mass Spectrom Rev; 2005; 24(6):828-46. PubMed ID: 15538747
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.